Larry D. Alphs, MD, PhD

  • 4Articles
  • 22.9KReads
  • 1999–2023Active
  • 33Collaborators
  • 154Citations

About

Larry D. Alphs has published extensively on topics related to schizophrenia and schizoaffective disorders, with a focus on antipsychotic treatments such as long-acting injectable paliperidone palmitate and clozapine. His work also addresses issues of suicidality, suicide risk, and drug safety concerns in psychiatric care. Alphs has contributed to consensus statements and analyses concerning suicide prevention and medication safety. He was affiliated with Janssen Scientific Affairs, LLC, during the time of these studies.

Publications

JCP
Earlier Use of Paliperidone Palmitate in Patients With Schizophrenia
Original Research

Earlier Use of Paliperidone Palmitate in Patients With Schizophrenia

September 25, 2023

Long-acting injectable antipsychotics (LAIs) are typically reserved for patients with a long history of schizophrenia. This analysis of 3 studies found benefit in initiating the LAI paliperidone palmitate earlier...
, , , et al
JCP
Consensus Statement

Suicidality and Risk of Suicide—Definition, Drug Safety Concerns, and a Necessary Target for Drug Development: A Consensus Statement

August 16, 2010

, , , et al
JCP
Consensus Statement

Suicidality and Risk of Suicide—Definition, Drug Safety Concerns, and a Necessary Target for Drug Development: A Brief Report

July 13, 2010

, , , et al
JCP
Article

Clozapine: The Commitment to Patient Safety

December 1, 1999

,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe